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FACTORS ASSOCIATED WITH LEFT VENTRICULAR
HYPERTROPHY IN ADULTS LIVING AT A HIGH
ALTITUDE CITY IN PERU
FACTORES ASOCIADOS A HIPERTROFIA VENTRICULAR IZQUIERDA EN PERSONAS ADULTAS EN UNA
CIUDAD DE ALTURA EN EL PERÚ
Aníbal Díaz-Lazo1,2,a, Carlos Barrientos-Huamani1,2,b, Carlo Cordova-Rosales1,2,b
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Introducción: Left ventricular hypertrophy has been described in people who live at high altitudes.
Objective: To determine the factors related to left ventricular hypertrophy (LVH) in adults. Methods: An
observational, cross-sectional and analytical study was carried out in the Echocardiography Laboratory of
the Daniel Alcides Carrión Regional Teaching Hospital (HRDCQ) in Huancayo, Peru; at 3 259 m.s.n.m. The
sampling was simple random. The variables were left ventricular hypertrophy (dependent), left ventricular
diastolic dysfunction, arterial hypertension, diabetes mellitus, body mass index, dyslipidemia, sedentary
lifestyle. The data were collected in a file. For the statistical analysis, the X2 test, student's t test, binary and
multivariate logistic regression were applied, the odds ratio and its 95% confidence interval were found. P
<0.050 was considered significant. Results: 488 patients were included, the average age was 64 years (range:
18-98). In 58.9% (370) they were women. The factors related to LVH were arterial hypertension (OR = 5.31; 95%
CI = 3.27 - 8.61), age older than 60 years (OR = 2.94; 95% CI = 1.93 - 4, 50), diabetes mellitus (OR = 3.33; 95% CI
= 1.15 - 9.79), and obesity (OR = 2.21; 95% CI = 1.16 - 4.19) compared to patients without LVH. In patients with
LVH, a higher left atrial volume index and left ventricular diastolic dysfunction were found.Conclusion: The
factors related to LVH in adults were hypertension, advanced age, diabetes mellitus and obesity..
Key words: Hypertension; Obesity; Diabetes mellitus; Risk factors (source: MeSH NLM).

RESUMEN
Introducción: La hipertrofia ventricular izquierda se ha descrito en personas que viven a gran altura.
Objetivo: Determinar los factores asociados a hipertrofia ventricular izquierda (HVI) en personas adultas.
Métodos: Se realizó un estudio observacional, transversal y analítico en el Laboratorio de Ecocardiografía
del Hospital Regional Docente Clínico Daniel Alcides Carrión (HRDCQ) de Huancayo, Perú; a 3 259 m.s.n.m.
El muestreo fue aleatorio simple. Las variables fueron hipertrofia ventricular izquierda (dependiente),
disfunción diastólica del ventrículo izquierdo, hipertensión arterial, diabetes mellitus, índice de masa
corporal, dislipidemia, sedentarismo. Los datos fueron recolectados en una ficha. Para el análisis estadístico
se aplicó la prueba chi cuadrado, t student, regresión logística binaria y multivariada, se halló el odds ratio, su
intervalo de confianza al 95%. Se consideró significativo p<0,050. Resultados: Se incluyeron 488 pacientes,
el promedio de edad fue de 64 años (rango: 18-98). En el 58,9% (370) fueron mujeres. Los factores asociados
a HVI fueron la hipertensión arterial (OR=5,31; IC95% = 3,27 – 8,61), la edad mayor a 60 años (OR=2,94; IC95%
= 1,93 - 4,50), la diabetes mellitus (OR= 3,33; IC95% = 1,15 - 9,79), y la obesidad (OR=2,21; IC95% = 1,16 4,19) en comparación a los pacientes sin HVI. En pacientes con HVI se encontró mayor índice del volumen
auricular izquierdo y disfunción diastólica del ventrículo izquierdo.Conclusión: Los factores asociados a HVI
en personas adultas fueron la hipertensión arterial, la edad avanzada, diabetes mellitus y obesidad.
Palabras clave: Hipertensión; Obesidad; Diabetes mellitus; Factores de riesgo (fuente: DeCS BIREME).
Departamento de Medicina, Hospital Regional Docente Clínico Quirúrgico Daniel A. Carrión, Huancayo-Perú.
Facultad de Medicina Humana, Universidad Peruana Los Andes, Huancayo-Perú.
a
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Population and sample

Left ventricular hypertrophy (LVH) is an independent
risk factor for cardiovascular morbidity and mortality.
LVH is a biomarker of cardiac damage that occurs
as a pathological adaptive response to high blood
pressure overload or other non-hemodynamic
changes, and is due in part to cardiomyocyte
hypertrophy(1-4). Multiple factors associated with
the occurrence of ventricular remodeling and LVH
have been reported, among which reference is
made to advanced age, race, gender, genetic factors,
arterial hypertension, diabetes mellitus, chronic
kidney disease, obesity, metabolic syndrome, apnea
obstructive sleep, sedentary lifestyle, dietary salt
intake and increased triglycerides(2,3,5-8).

The population was made up of 5,687 patients
evaluated during the study period. The sample size
was determined using Epidat version 3.1, considering
a frequency of the event of interest of 50% and
5% precision(4,12), requiring a minimum sample
of 360 patients. The selection of the sample was
carried out by means of simple random probability
sampling. Patients 18 years of age or older and with
an echocardiography study were included. Patients
with incomplete echocardiography study, valve
disease diagnosis, congenital heart disease, dilated
cardiomyopathy, acute cardiovascular event or
cardiac arrhythmia were excluded.

The presence of type 2 diabetes mellitus is reported
to increase the risk of LVH by approximately 1.5
times more(9). At the heart level, the hypertrophied
myocardium shows fibrosis, alterations in the
coronary circulation, and apoptosis of the
cardiomyocyte, which can lead to heart failure,
myocardial ischemia, and arrhythmias(2). On the
other hand, LVH was associated with a more than
3-fold probability of myocardial ischemia (OR = 3.27)
in patients with angina pectoris and non-obstructive
coronary disease(10), in addition to the risk of mortality
in individuals with LVH is 3 to 4 times higher than in
people without LVH(11).

LThe study variables had the following definitions:

The presence of LVH in the population that lives in
height could be related to various modifiable factors.
Its determination will affect the timely and adequate
control of this disease. However, in patients who
live above 3,000 meters above sea level, the factors
associated with LVH have not been described with
the frequency reported at lower altitudes. It is likely
that there could be variations in those chronically
exposed to hypobaric hypoxia of the height.
Therefore, the objective of this study is to determine
the factors associated with LVH in adults.

METHODS
Design and study area
Observational, cross-sectional, an analytical
study based on the patients who attended the
Echocardiography Laboratory of the Daniel Alcides
Carrión Regional Teaching Hospital (HRDCQ) of
Huancayo from January 2017 to June 2019.

https://inicib.urp.edu.pe/rfmh/vol21/iss1/10

Variables and Instruments
Left ventricular hypertrophy (LVH): defined by the
increase in left ventricular mass (LVM)> 115 g /
m2 in men and> 95 g / m2 in women(13). Eccentric
hypertrophy (MVI> 115 g / mhypertrophy (MVI> 115
g /2 and GRP < 0.42) and concentricm2 and GRP>
0.42)(13).

ORIGINAL PAPER

INTRODUCTION

Diastolic dysfunction of the left ventricle (LVDD): It
is the deterioration of the isovolumic ventricular
relaxation and the decrease in the compliance of the
left ventricle that was determined by having three or
more of the following criteria: septal tissue velocity
e´ <7 m / s and/or lateral tissue velocity e '<10 m / s;
E / e 'ratio> 14; left atrial volume index> 34 ml / m2;
tricuspid valve regurgitation velocity> 2.8 m / s(13).
Arterial hypertension: with a blood pressure level
greater than or equal to 140/90 mmHg, having
normal values with drug treatment, and having a
history of arterial hypertension(14,15).
Diabetes mellitus: having fasting blood glucose
greater than 125 mg/dl, or a normal value with
antidiabetic treatment and a history of diabetes(14,15).
Body mass index (BMI): determined by the
relationship between body weight (Kg) and height
(m) squared, a BMI between 25 and 29.9 is considered
overweight and 30 or more obese(14,15).
Dyslipidemia: determined with total cholesterol
values> 200 mg / dl, HDL cholesterol <50 mg / dl in
women and <40 mg / dl in men, LDL cholesterol>
130 mg / dl and triglycerides> 150 mg / dl(14,15).
Sedentary lifestyle reports that they cannot do
physical activity for more than 30 minutes per day (15).
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Procedures
The reports of the HRDCQ echocardiographic
examinations registry were reviewed, which were
reflected in a data record sheet where: age, gender,
clinical characteristics and demographic associated
factors were included. LVH, relative ventricular wall
thickness (GRP), left atrial volume index (VIA), and
LVED were determined. The study was performed
with a General Electric Vivid S50 echocardiography
with cardiology software, with a 2.5 MHz transducer.
Echocardiographic measurements were performed
according to the guidelines of the American Society
of Echocardiography(13).

ORIGINAL PAPER

Statistic analysis
The Microsoft Excel program was used to process
and enter the data. For the analysis, the statistical
analysis was used in the statistical package for
social sciences (SPSS) version 25. The Kolmogorov
Smirnov test was used to evaluate the normal
distribution of the groups. Continuous data are
expressed as mean (X) and standard deviation
(SD), while categorical variables are reported in
frequencies and percentages. The student’s t-test
was used to analyze whether there were significant
differences between the quantitative variables.
The chi-square test was used for the comparison
between categorical variables. A value of p <0.05
was considered significant. For the hypothesis test,
binary and multivariate logistic regression was used.
Qualitative variables with very small frequencies that
made their analysis difficult were excluded from the
multivariate model, the odds ratio (OR) and the 95%
confidence interval (CI) were found.

Ethical considerations
During the research process, the bioethical principles
of research in humans have been respected. The
data collected was handled with the reserve and
confidentiality of the case. The Research Ethics
Committee approved the research project of the

Pág.
Published
by84INICIB-URP, 2021

Díaz A et al

HRDCQ of Huancayo.

RESULTS
488 (100%) patients with a mean age of 63.3 ± 17.7
years (range: between 18 and 98) were included.
57.4% (280) were women, and 42.6% (208) were
men. 80.1% (391) came from Huancayo, 4.7% (23)
from Chupaca, 4.5% (22) from Huancavelica, 3.3%
(16) from Jauja, 3.1% (15), cities located more than
3,200 meters above sea level. Table 1 comparatively
shows patients with and without LVH. It was found
that in the group of patients with LVH, they were
older, with higher levels of the LVH index body
mass, pulse pressure, and systolic and diastolic
blood pressure, compared to patients without LVH.
Likewise, a higher index of left atrial volume (LA) and
LV diastolic dysfunction was observed in patients
with LVH compared to those who did not present
LVH.
In Figure 1, it is shown that LVH is more frequent in
women between 50 and 69 years of age in a ratio of
1.8 to 1 compared to men (48.3% vs. 26.8%; p <0.001),
while between 70 and 99 years LVH is more frequent
in men compared to women in a proportion of 1.51
to 1 (64.9% vs. 42.9%; p <0.001)
Table 2 shows that the factors associated with LVH
compared to patients without LVH were over 60
years of age, arterial hypertension, obesity, and
diabetes mellitus. Likewise, there were no differences
in relation to gender, overweight, dyslipidemia, and
sedentary lifestyle.
Table 3, when performing the multivariate analysis,
it was found that the factors associated with patients
with LVH compared to patients without LVH were
arterial hypertension (OR = 5.31; 95% CI = 3.27 8.61), age older than 60 years (OR = 2.94; 95% CI =
1.93 - 4.50), diabetes mellitus (OR = 3.33; 95% CI =
1.15 - 9.79) and obesity ( OR = 2.21; 95% CI = 1.16 4.19).
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Table 1. Demographic, clinical, and echocardiographic characteristics of the patients.
Without LVH
n2= 244

P-value

Age (years), X ± SD

69.1±13.8

57.5±19.4

<0.001

Weight (Kg), X ± SD

62.2±12.6

59.4±10.9

0.008

Height (m), X ± SD

1.5 ±0.1

1.6±0.18

0.019

Body mass index (Kg / m2), X ± SD

26.2 ±4.8

24.4±3.7

<0.001

Systolic blood pressure (mmHg), X ± SD

121.7±19.3

112.7 ±16.9

<0.001

Diastolic blood pressure (mmHg), X ± SD

74.8 ±13.1

71.4±11.7

0.001

Pulse pressure (mmHg) X ± SD

46.9 ±15.9

41.2 ±11.5

<0.001

Heart rate (L / min) X ± SD

68.6±11.3

71.7 ±13.6

0.061

Left ventricular mass index (g / m2), X ± SD

140.6±34.4

84.7±15.8

<0.001

Relative ventricular wall thickness (GRP), X ± SD

0.52 ±0.1

0.45±0.1

<0.001

Left ventricular ejection fraction (%), X ± SD

70.6 ±7.4

71.7 ±6.5

0.085

Cardiac output (L / min), X ± SD

5.03 ±1.4

4.92 ±1.3

0.061

Left atrial volume (ml/m2), X ± SD

35.7±15.0

27.6 ±12.0

<0.001

Diastolic dysfunction of ve Left nerve (n,%)

154 (63.1)

91 (37.3)

<0.001

ORIGINAL PAPER

With LVH
n1= 244

Characteristics

Source: Data record sheet. HVI. 2017-2019.

Table 2. Risk factors associated with left ventricular hypertrophy.
With LVH
n1= 244

Without LVH
n2= 244

p-value

Age> 60 years (n,%)

186 (76.2)

125 (51.2)

<0.001

Female (n,%)

147 (60.2)

133 (54.5)

0.200

Hypertension (n,%)

109 (44.7)

30 (12.3)

<0.001

Diabetes mellitus (n,%)

15 (6.1)

6 (2.5)

0.045

Overweight (n,%)

99 (40.6)

92 (37.7)

0.516

Obesity (n,%)

44 (18.0)

19 (7.8)

0.001

Dyslipidemia (n,%)

10 (4.1)

2 (0.8)

0.019

Sedentary(n,%)

3 (1.2)

2 (0.8)

0.653

Associated factor

Source: Data record sheet. HVI. 2017-2019

https://inicib.urp.edu.pe/rfmh/vol21/iss1/10
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Table 3. Multivariate statistical analysis of factors associated with left ventricular hypertrophy.
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Associated factor

adjusted OR

95% CI

p-value

Age> 60 years

2.94

1.93 - 4.50

<0.001

Female

1.27

0.85 - 1.92

0.237

Hypertension

5.31

3.27 - 8.61

<0.001

Diabetes mellitus

3.36

1.15 - 9.79

0.026

Overweight

0.92

0.60 - 1.41

0.716

Obesity

2.21

1.16 - 4.19

0.015

Dyslipidemia

2.74

0.44 - 16.87

0.275

Sedentary

0.27

0.03 - 2.04

0.207

Source: Data record sheet. HVI. 2017-2019

Graphic 1. Distribution of patients with left ventricular hypertrophy according to age and gender.
DISCUSSION
LLVH is an independent predictor of cardiovascular
and general mortality(16). LVH is an adaptive response
of the heart to physiological or pathological stimuli,
classified as concentric and eccentric, is caused
by pressure or volume overload(17). There are
mechanical, neurohumoral, and genetic factors
that promote LVH, which act on the left ventricular
mass and geometry(18,19). Body mass index (BMI) and
systolic blood pressure are independent factors
of LVM and both factors interact(20). In our series,
Pág.
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both factors were associated with elevated levels
in patients with LVH compared to patients without
LVH. Likewise, the increased left atrial volume index
has been reported to be associated with LVH and LV
diastolic dysfunction(21). In our casuistry, we also find
similar relationships.
Age by itself is a great predictor of cardiovascular
disease. Increasing age makes cellular, structural, and
functional changes in the heart. These maladaptive
changes are more accentuated in older adults with
a high degree of frailty(22). On the other hand, there
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is evidence that the number of ventricular myocytes
decreases with age due to apoptosis in men but
not in women(23). According to Cuspide et(24),
evaluating 3752 hypertensive patients has observed
that LVH and severity increase with age. ValarezoSevilla et al.(25) evaluated 91 diabetic patients and
reported a relationship between LVH and age with
the highest prevalence in older adults. We found
very similar findings in our series, LVH becoming
more pronounced after 50 years of age, with a
predominance in women between 50 and 69. While
between 70 and 99 years old, LVH is more frequent in
men than women in a ratio of 1.51 to 1.

High blood pressure is one of the most important
causative factors of LVH. The prevalence of LVH in
hypertensive patients ranges between 20% and 92%,
this variability being related to the method and the
diagnostic criteria used, as well as the demographic
differences and comorbidities that the study
population presents, such as increasing age, gender,
genetic factor, diabetes mellitus, obesity, chronic
kidney disease; the duration, severity and lack of
treatment of arterial hypertension and according
to the diagnostic criteria used(11,27-30). Likewise, LVH
has been reported in normotensive patients with
obesity in 13% and increases to more than 75% in
hypertensive patients with morbid obesity(2).
Systolic arterial hypertension is associated with
a high percentage with the incidence of LVH(19).
LVH is a common finding, even in those patients
with onset of arterial hypertension, and it is not
necessarily a marker of long-term hypertension. In
a Korean study, they found a progressive increase
in the risk of ventricular remodeling in controlled
hypertensive patients (OR = 2.02), in newly
diagnosed hypertensive patients (OR = 2.85), and
in uncontrolled hypertensive patients (OR = 3.31)
in comparison to normotensive(31). Our series found
that patients with arterial hypertension have a 5
times higher risk of presenting LVH (OR = 5.31; 95%
CI = 3.27 - 8.61) than non-hypertensive patients.
In the heart of obese people, there is interstitial
https://inicib.urp.edu.pe/rfmh/vol21/iss1/10
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In a previous study, a higher frequency of LVH was
reported in women than in men (43, 4% vs. 32.1%)
(24). Another study found a higher prevalence in
women in relation to men (47.1% vs. 26.9%) in
people 60 years of age and older(26). We also found a
higher frequency of LVH in women, but only in those
under 60 years of age, which can be explained by the
greater influence of visceral obesity on ventricular
mass and ventricular geometry(18).

fatty infiltration, growth of the cardiomyocyte, and
accumulation of triglycerides in the heart’s contractile
elements, which contribute to the higher probability
of LVH compared to non-obese(32). Overweight
and obesity are independent risk factors for LVH in
hypertensive patients(32-34). Therefore cardiovascular
risk will increase in this group of patients. Gómez et
al.(35)reported that obesity is a powerful determinant
of LVH (OR = 12.29; 95% CI 2.48 - 60.76). Guerra
et al.(34) reported that LVH is strongly associated
with a higher body mass index and systolic blood
pressure in overweight and obese hypertensive
patients. A previous study found a frequency of
LVH in hypertensive women with normal weight in
7.1%, overweight in 41.2% and obesity in 66.7%, and
overweight was associated as a predictor of eccentric
development LVH (OR = 31.82)(16). However, Avelar et
al.(36) evaluating patients with severe obesity found
a higher frequency of concentric LVH. In our study,
we found that obesity was associated with a higher
possibility of presenting LVH, but less frequently
than previously reported (OR = 2.21; 95% CI = 1.16 4.19), showing the concentric ventricular geometric
pattern in 90% of the cases and it was more frequent
in women with obesity (70%).
In previous studies, it has been reported that
diabetes mellitus was associated with LVH between
19.3% and 71%)(8,26,37), however not all patients with
diabetes develop LVH, which suggests that there is a
genetic component involved in the presence of LVH
(38). According to Palmieri et al.(39), the probability of
LVH was 1.32 times higher (OR = 1.43; 95% CI: 1.021.70) in hypertensive diabetics than in non-diabetics
regardless of gender, blood pressure, and obesity;
and according to Eguchi et al.(9), the presence of
diabetes increased the risk of LVH by 1.46 times
more (OR = 1.46; 95% CI: 1.13 - 1.88; p = 0.004).
Kim et al.(40) report that patients with overweight or
obesity, and type 2 diabetes are more likely to suffer
from LVH (OR = 2.24). De Jong et al.(20), reports that
in normotensive people with obesity and diabetes
mellitus 2 have the risk of suffering from LVH. This
increases when it is accompanied by increased pulse
pressure and fasting glycemia. In our series, we
found that diabetes mellitus is 3 times more likely to
develop LVH compared to non-diabetic patients (OR
= 3.33; 95% CI = 1.15 - 9.79).
A limitation of the study was not determining
causality because it was a retrospective design,
and the sample was mostly patients who attended
the hospital, so its extrapolation to the general
population should be taken with caution.
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CONCLUSION
It is concluded that in adult patients, the factors
associated with LVH were arterial hypertension,
advanced age, diabetes mellitus, and obesity.

Likewise, a higher rate of LA volume and LV diastolic
dysfunction was evidenced in patients with LVH
compared to those who did not present LVH.
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